Back to Search
Start Over
Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review.
- Source :
-
BMC health services research [BMC Health Serv Res] 2010 Jan 19; Vol. 10, pp. 19. Date of Electronic Publication: 2010 Jan 19. - Publication Year :
- 2010
-
Abstract
- Background: The effectiveness of collaborative care for patients with major depressive disorder in primary care has been established. Assessing its cost-effectiveness is important for deciding on implementation. This review therefore evaluates the cost-effectiveness of collaborative care for major depressive disorder in primary care.<br />Methods: A systematic search on economic evaluations of collaborative care was conducted in Pubmed and PsychInfo. Quality of the studies was measured with the Cochrane checklist and the CHEC-list for economic evaluations. Cost-effectiveness and costs per depression-free days were reported.<br />Results: 8 studies were found, involving 4868 patients. The quality of the cost effectiveness studies, according to the CHEC-list, could be improved. Generally, the studies did not include all relevant costs and did not perform sensitivity analysis. Only 4 out of 8 studies reported cost per QALY, 6 out of 8 reported costs per depression-free days. The highest costs per QALY reported were $49,500, the highest costs per depression-free day were $24.<br />Conclusions: Although studies did not fulfil all criteria of the CHEC-list, collaborative care is a promising intervention and it may be cost-effective. However, to conclude on the cost-effectiveness, depression research should follow economic guidelines to improve the quality of the economic evaluations.
Details
- Language :
- English
- ISSN :
- 1472-6963
- Volume :
- 10
- Database :
- MEDLINE
- Journal :
- BMC health services research
- Publication Type :
- Academic Journal
- Accession number :
- 20082727
- Full Text :
- https://doi.org/10.1186/1472-6963-10-19